clean_2026_Stroke_Clinical_Blueprint

THE CLINICAL BLUEPRINT 2026 AHA/ASA ACUTE ISCHEMIC STROKE GUIDELINES A Clinical Blueprint: Distilled Algorithms, Paradigm Shifts, and Physiological Targets Target Audience: Neurologists, ED Physicians, Stroke Teams, & Residents UPDATED 2026 DELTA INCLUDED.

INTRODUCTION I THE 2026 PHILOSOPHY Precision Over Generalization: The Era of Targeted Thresholds Diagnostic Urgency Shift to strict, time-bound imaging algorithms (Door-to-Imaging < 25 mins) and the introduction of DTAs (Direct Triage to Angiography Suite). Definitive Action Transition from Alteplase to Tenecteplase as the primary lytic, and the formal inclusion of specialized pediatric protocols. Physiological Stabilization Introduction of Goldilocks Zones for supportive care. Moving from aggressive interventions to permissive, tightly monitored ranges. The recurring theme of 2026: Avoiding physiological over-correction. Intensive reduction of blood pressure or glucose is formally recognized as harmful..

PILLAR 1: IMAGING I THE DOOR-TO-IMAGING PROTOCOL The 25-Minute Objective: Bypassing Diagnostic Delays Clinical deficit assessment using standardized scales (NIHSS / modified NIHSS). Emergent non-contrast CT or MRI to assess ischemic burden (ASPECTS) and exclude hemorrhage. Minute O: Door Minute 10 Contrast enhancement (CTA/CTP) MUST NOT be delayed to obtain serum creatinine. Overall rate of AKI in patients undergoing CTA/CTP is only 3%, and hemodialysis risk is 0.07%—even with known chronic kidney disease. Minute 25: Imaging.

PILLAR 1: IMAGING I ADULT ALGORITHM Time = Tissue: Imaging Modality by Time-from-Onset < 4.5 Hours (or < 6 Hours for EVT) 4.5 to 24 Hours (Extended Window) Patient Onset Wake-Up Stroke / Unknown Onset Recommend Non-contrast CT + CTA (or MRI + MRA). Advanced perfusion imaging is not required. Recommend CTP or MRI (DWI/PWI) utilizing automated post-processing software to determine ischemic core vs. salvageable penumbra volume. Recommend MRI (DWI/FLAIR mismatch) or CTP to determine eligibility for extended-window IVT or EVT. RULE OF THUMB: Aim is to rule out bleed, not necessarily to find a stroke. Do not delay IVT for perfect imaging if a disabling clinical diagnosis is clear..

PILLAR 1: IMAGING I EXTENDED WINDOW SELECTION The Mismatch Model: Quantifying the Penumbra eDe Penumbra Ischemic Core (Unsalvageable) DWI/FLAIR Mismatch Identifies patients whose stroke is seen on Diffusion-Weighted Imaging (DWI) but has not yet developed on Fluid-Attenuated Inversion Recovery (FLAIR)—indicating an onset likely <4.5 hours. CTP Automated Software Requires automated post-processing software to definitively calculate the core volume (<70ml typically targeted for EVT) vs. perfusion mismatch. Visual estimation is no longer acceptable..

PILLAR 1: IMAGING I PEDIATRIC PROTOCOL (2026 UPDATE) The Pediatric Exception: Prioritizing MRI over CT Adult Protocol (Baseline) • Primary Modality: Non-contrast CT + CTA • Rationale: Fastest acquisition time to detect hemorrhage and LVO. Pediatric Protocol (2026 Update) • Primary Modality: MRI + MRA of cervical and intracranial vessels (Class 2A). • Rationale: Superior for differentiating true arterial ischemic stroke from frequent pediatric stroke mimics (e.g., seizures) and avoids ionizing radiation. O The CT Caveat: CT/CTA is only reasonable if MRI is unavailable within the strict 25-minute window. If CT is used, pediatric-specific dose reduction strategies MUST be employed..

PILLAR 1: IMAGING I PRE-HOSPITAL TRIAGE DTAS: Direct Triage to Angiography Suite Traditional Workflow Ambulance CT Scanner Assessment DTAS Workflow (The 2026 Shortcut) Ambulance (RACE Score >4 / Suspected LVO) Angio Suite Bypasses ED -> Direct to Flat- Panel Head CT in Cath Lab Immediate EVT. Implementation Note: Class 2B recommendation. Significantly reduces door-to-groin-puncture and door-to-reperfusion times, though evidence relies primarily on specialized thrombectomy centers..

PILLAR 2: THROMBOLYSIS I THE DISABILITY THRESHOLD Deciding on IVT for Minor Strokes (NIHSS 0-5) No Is the stroke disabling? Yes The Non-Disabling Path: IVT is not recommended. The Disabling Path (Class IA, <4.5 hours): IVT is strictly recommended. The 2026 Disabling Criteria Checklist Ü Hemianopia (Visual question >= 2) Ü Severe Aphasia C] (Language question >= 2; fragmented speech) Hemi-attention/Extinction (Present in >= 2 modalities) Motor Weakness (Limiting effort against gravity, Motor >= 2) Functional Impact (Prevents ambulation, swallowing, basic ADLs, or returning to specialized work).

PILLAR 2: THROMBOLYSIS I AGENT SELECTION The Lytic Shift: Tenecteplase vs. Alteplase Feature Administration Monitoring Dosing Protocols Tenecteplase Single Bolus (5 seconds) Immediate effect, no infusion pump needed AHA: 0.25 mg/kg (Indian DCGI: 0.2 mg/kg validation) Alteplase Bolus + I-hour Infusion Risk of intra-infusion anaphylaxis/headache requiring stoppage 0.9 mg/kg 2026 Verdict TNK prevents diagnostic delays; imaging transport can happen immediately. TNK offers superior operational efficiency. TNK is the preferred primary lytic for adults. Clinical Note: Even without a frank hypodensity or high ASPECTS score, any disabling stroke eligible for lysis should be treated. Do not withhold IVT based solely on a minor NIHSS score..

PILLAR 2: THROMBOLYSIS I PEDIATRIC PROTOCOL (2026 UPDATE) Pediatric Reperfusion: 28 Days to 18 Years Age < 28 days: No thrombolysis recommended. Age 28 days to 18 years: Thrombolysis permitted for confirmed disabling strokes within the 4.5-hour window. THE 'ALTEPLASE ONLY' WARNING: Tenecteplase is NOT approved for pediatric use. Alteplase remains the sole approved agent (Class 2A evidence). Do not apply adult Tenecteplase rules to children..

PILLAR 3: SUPPORTIVE CARE I OXYGENATION Oxygen Supplementation: The Normobaric Hyperoxia Update General Rule (Path 1) Is sp02 Yes Provide supplemental 02 to maintain 94-97%. No Do NOT supplement. Routine oxygen in non-hypoxic patients yields no benefit and may worsen outcomes. The 2026 Exception (Path 2) Is the patient <6h from onset, NIHSS 10-20, ASPECTS with an LVO, and planned for EVT? Yes Provide Normobaric Hyperoxia before EVT. This specific pre-EVT oxygenation is reasonable to improve 90-day functional outcomes (Class 2A). NOTE: Hyperbaric oxygen is strictly NOT recommended unless the stroke is explicitly caused by an arterial air embolism..

PILLAR 3: SUPPORTIVE CARE I PRE-REPERFUSION BP Blood Pressure Targets: Permissive vs. Strict Control 80 — 80 — 60 — 60 — 40 — 40 — 20 — 20 — o— Pre-IVT Target 220 — 200 — <185/110 mmHg 160 — 140 — 100 — No Reperfusion Planned Must be lowered before initiating thrombolytics to reduce hemorrhagic complications. 220/120 mmHg 220 — 200 — 180 — 160 — 120 — 100 — Permissive hypertension is allowed up to this threshold to maintain cerebral perfusion. The 220/120 Rule If BP >220/120 and no IVT/EVT is planned, the benefit of initiating anti-hypertensives in the first 48-72 hours is uncertain. Individualize management with an initial reduction of only 15% if concurrent organ damage exists..

PILLAR 3: SUPPORTIVE CARE I POST-REPERFUSION BP The Post-Intervention BP 'Goldilocks Zone' Intensive lowering <140 mmHg for the first 72 hours post-EVT causes early neurological o o o o o o deterioration. 120 140 TARGET: 140-180 mmHg (and <105 Diastolic). Maintain for at least 24 hours post-IVT/EVT. 160 180 High risk of hemorrhagic transformation. 200 Systolic Blood Pressure (mmHg) Do not artificially crash the blood pressure—cerebral auto-regulation requires perfusion pressure..

PILLAR 3: SUPPORTIVE CARE I PHYSIOLOGICAL STABILIZATION The Stabilization Dashboard: Glucose, Temp, & Positioning Glycemic Control 150 120 180 øtgange: 90 220 260 mg/dL 300+ Temperature 35 30 30 37 25 Head Positioning 20 30 40 375 35 30 32.5 37.5 25 20 35 60 30 37.5 30 37.5 10 -20 -20 -30 50 60 60 — +70 — +80 +90 Target Range: 140—180 mg/dL. Floor Rule: Treat any hypoglycemia <60 mg/dL. Ceiling Rule: Intensive insulin therapy to force glucose to 80-130 mg/dL is NOT recommended (increases hypoglycemia risk without functional benefit). Target Normothermia. Treat sources of fever immediately. Prophylactic induced hypothermia provides no benefit and is not recommended. Flat (0 degrees) or elevated (30 degrees) show identical outcomes. Avoid Trendelenburg (-20 degrees) due to severe aspiration risk..

PILLAR 3: SUPPORTIVE CARE I SECONDARY DIAGNOSTICS The Non-lnterference Rule for Systemic Diagnostics Required Baselines Baseline Echocardiography and Serum Troponin assessment are Class 1 recommendations to identify causative factors and aid prognosis. The Priority p s Acquiring these investigations MUST NOT delay the initiation of IVT or EVT..

2026 SYNTHESIS I THE DELTA MATRIX 2019 vs. 2026: The Critical Paradigm Shifts Clinical Domain Primary Lytic Post-intervention BP Oxygenation Pediatric Protocol 2019 Standard Alteplase Aim lower if possible 2026 Standard Tenecteplase preferred for adults Strictly 140-180 mmHg (<140 target studied) only if sp02 Ambiguous / Extrapolated sp02 AND Normobaric hyperoxia prior to EVT in <6h LVO MRI preferred, Alteplase only for 28d-18y The Rationale Faster bolus, equal/better efficacy, no infusion pump required. <140 mmHg proven harmful; starves the penumbra of perfusion pressure. Preserves at-risk tissue during mechanical EVT setup. Reduces radiation and avoids frequent pediatric stroke mimics..

CONCLUSION I THE CLINICAL BOTTOM LINE The Physiology of Restraint • Protect the Collaterals. Avoid intensive reductions in blood pressure (<140 mmHg) or glucose (<130 mg/dL). The injured brain relies on auto-regulated physiological surges to maintain necessary perfusion. • Treat the Patient, Not the Score. A low NIHSS (0-5) does not preclude treatment if the stroke disables the patient's daily life, ambulation, or profession. • Time Defeats Perfection. Do not delay reperfusion for serum creatinine checks, perfect MRI alignments in clear <4.5h cases, or secondary echo/troponin diagnostics. The 2026 guidelines demand precision in diagnosis, speed in intervention, and measured restraint in physiological stabilization,.